CREG1 enhances p16(INK4a) -induced cellular senescence.
Cellular senescence is an irreversible growth arrest that is activated in normal cells upon shortening of telomere and other cellular stresses. Bypassing cellular senescence is a necessary step for cells to become immortal during oncogenic transformation. During the spontaneous immortalization of Li-Fraumeni Syndrome (LFS) fibroblasts, we found that CREG1 (Cellular Repressor of E1A-stimulated Genes 1) expression was decreased during immortalization and increased in senescence. Moreover, we found that repression of CREG1 expression occurs via an epigenetic mechanism, promoter DNA methylation. Ectopic expression of CREG1 in the immortal LFS cell lines decreases cell proliferation but does not directly induce senescence. We confirmed this in osteosarcoma and fibrosarcoma cancer cell lines, cancers commonly seen in Li-Fraumeni Syndrome. In addition, we found that p16 (INK4a) is also downregulated in immortal cells and that coexpression of CREG1 and p16 (INK4a) , an inhibitor of CDK4/6 and Rb phosphorylation, has a greater effect than either CREG1 and p16 (INK4a) alone to reduce cell growth, induce cell cycle arrest and cellular senescence in immortal LFS fibroblasts, osteosarcoma and fibrosarcoma cell lines. Moreover, cooperation of CREG1 and p16 (INK4a) inhibits the expression of cyclin A and cyclin B by inhibiting promoter activity thereby decreasing mRNA and protein levels; these proteins are required for S-phase entry and G2/M transition. In conclusion, this is the first evidence to demonstrate that CREG1 enhances p16 (INK4a) -induced senescence by transcriptional repression of cell cycle-regulated genes.
Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Benchamart
B
Moolmuang
Michael A
MA
Tainsky
D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D016922:Cellular Senescence / Q000235:genetics*; D018899:CpG Islands; D019925:Cyclin A / Q000378:metabolism; D019926:Cyclin B / Q000378:metabolism; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics / Q000502:physiology*; D019175:DNA Methylation; D015536:Down-Regulation; D044127:Epigenesis, Genetic; D006801:Humans; D011401:Promoter Regions, Genetic; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
C114068:CREG1 protein, human; D019925:Cyclin A; D019926:Cyclin B; D019941:Cyclin-Dependent Kinase Inhibitor p16; D012097:Repressor Proteins
Mol Cell Biol. 1999 May;19(5):3916-28
10207115
Annu Rev Biochem. 1992;61:307-30
1323236
Nucleic Acids Res. 1996 Jul 15;24(14):2849-56
8759021
Mol Cell Biol. 1998 Sep;18(9):5032-41
9710587
Mol Cell Biol. 1996 Mar;16(3):859-67
8622687
Cardiovasc Res. 2008 Jun 1;78(3):597-604
18267954
Oncogene. 1997 May 22;14(20):2395-406
9188854
Oncogene. 2003 Jun 26;22(26):4118-27
12821946
Science. 1990 Nov 30;250(4985):1233-8
1978757
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13742-7
8943005
Mol Cell Biol. 1994 Apr;14(4):2291-7
8139534
J Struct Biol. 2007 Jul;159(1):56-70
17428679
Mol Cell Biol. 1995 Sep;15(9):4745-53
7651392
Exp Cell Res. 1991 Sep;196(1):33-9
1652450
Hum Mol Genet. 2001 Apr;10(7):687-92
11257100
Cell Death Differ. 2006 Feb;13(2):324-34
16123778
Cell Growth Differ. 1998 Feb;9(2):139-46
9486850
Mol Cell Biol. 2006 Apr;26(7):2501-10
16537896
Anal Biochem. 2000 Oct 15;285(2):194-204
11017702
Cancer Res. 2005 Apr 1;65(7):2690-7
15805267
Oncogene. 1998 Jan 15;16(2):265-72
9464545
Mol Cell Biol. 1998 May;18(5):3089-100
9566927
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18326-31
16344469
Oncogene. 2000 Mar 23;19(13):1613-22
10763818
J Cell Mol Med. 2009 Jul;13(7):1302-13
19413895
Oncogene. 2009 Oct 1;28(39):3456-67
19648966
Oncogene. 2001 May 28;20(24):3156-65
11420732
Oncogene. 1991 Feb;6(2):183-6
2000218
Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40
17667954
Exp Cell Res. 1965 Mar;37:614-36
14315085
Genes Cells. 2008 Sep;13(9):977-86
18691225
Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6289-93
7603984
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
7568133
J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):879-89
16960018
Oncogene. 2003 Aug 21;22(35):5436-45
12934103
J Vasc Surg. 2008 Jul;48(1):201-9
18472385
Pharmacol Ther. 1995 Jan;65(1):19-46
7536332
Exp Cell Res. 2009 Nov 15;315(19):3301-11
19769965
Cancer Res. 1990 Dec 15;50(24):7979-84
2253239
Oncogene. 2000 Apr 20;19(17):2120-8
10815803
Ann Intern Med. 1969 Oct;71(4):747-52
5360287
Biochimie. 2002 Jan;84(1):75-82
11900879
Mol Cell Biol. 1999 Mar;19(3):2109-17
10022898
Mol Cancer Res. 2008 May;6(5):770-84
18505922